Listing Center Rulebook Relocation Banner
Reference Library - Advanced Search


** To make multiple selections, select the first criterion and then press and hold the Ctrl Key **
1- 1 of 1 Search Results for:
Libraries:   FAQs - Listings
Filters:   Board Composition/Committee Assignments;
Search   Clear

Expand All
Printer Friendly View
Mailto Link 
Page: 1 of 1
Frequently Asked Questions
  What is the applicable cure period when a Company becomes non-compliant with the audit committee composition requirement because a director does not stand for re-election at the annual shareholders meeting?
Identification Number 1042
When a company becomes non-compliant with the audit committee composition requirement because of a vacancy created when a director does not stand for re-election, the company generally is afforded a cure period until the earlier of the company's next annual meeting or one year from the anniversary of the meeting causing non-compliance.  A company that finds itself in this situation must contact Listing Qualifications as soon as it is aware of the issue.
Publication Date*: 7/31/2012 Mailto Link Identification Number: 1042
material_search_footer*The Publication Date reflects the date of first inclusion in the Reference Library, which was launched on July 31, 2012, or a subsequent update to the material. Material may have been previously available on a different Nasdaq web site.
Page: 1 of 1
App Store       Google Play       Listing Center Content RSS Feed
The Nasdaq Stock Market, Nasdaq, The Nasdaq Global Select Market, The Nasdaq Global Market, The Nasdaq Capital Market, ExACT and Exchange Analysis and Compliance Tracking system are trademarks of Nasdaq, Inc.
FINRA® and Financial Industry Regulatory Authority, Inc.® are registered trademarks of Financial Industry Regulatory Authority, Inc. OTCBBTM and OTC Bulletin BoardTM are trademarks of FINRA